Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study.

CRCI is a true risk also in gynecological cancer survivors. The cognitive impairment does not seem to be dependent on depression state after treatment or to a menopausal condition. Assessing cognitive decline in cancer survivorship is essential for ensuring the optimum quality of life and functioning.